Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 147 Results

Title
Intervention Indication Therapeutic Area Year Actions
Tislelizumab in combination with chemotherapy for nasopharyngeal cancer – first line Cisplatin (Platinol) , Gemcitabine (Gemzar; gemcitabine hydrochloride) , Tislelizumab (BGB-A317; BGBA-317) Nasopharyngeal cancer Head and Neck Cancer 2021 View  |  Download
Tislelizumab with chemotherapy for previously untreated advanced squamous or non-squamous non-small-cell lung cancer Tislelizumab (BGB-A317; BGBA-317) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Topical sirolimus for angiofibroma in tuberous sclerosis complex Sirolimus (Rapamune; NPC-12G; Opsiria; DE-109) Tuberous sclerosis Genetic Disorders 2021 View  |  Download
Trastuzumab deruxtecan for HER2 mutant unresectable and/or metastatic non-squamous non-small cell lung cancer – second line Trastuzumab deruxtecan (DS-8201a; Enhertu) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Trastuzumab deruxtecan for HER2-positive gastric or gastroesophageal junction adenocarcinoma – third-line Trastuzumab deruxtecan (DS-8201a; Enhertu) Gastric cancer , Gastro-oesophageal junction cancer Gastrointestinal Cancer 2021 View  |  Download
Trastuzumab deruxtecan for unresectable or metastatic HER2-low (HR+/-) breast cancer – after chemotherapy Trastuzumab deruxtecan (DS-8201a; Enhertu) Breast cancer Breast Cancer 2021 View  |  Download
Triheptanoin for long-chain fatty acid oxidation disorders Triheptanoin (UX007; Dojolvi) Long chain fatty acid oxidation disorders (LC-FAOD) Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Trofinetide for Rett syndrome Trofinetide (NNZ-2566) Rett syndrome Genetic Disorders , Neurology 2021 View  |  Download
Tusamitamab Ravtansine for previously treated advanced Non-Small-Cell Lung Cancer Tusamitamab ravtansine (SAR408701) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2021 View  |  Download
Upadacitinib for moderate to severe active Crohn’s disease Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications